ABT-751 (E7010) - ≥98% , Tubulin beta inhibitor, CAS No.141430-65-1, Tubulin beta inhibitor
Em stock
SKU
A125698
Antimitotic agent. Microtubule polymerization inhibitor.
"}
Antimitotic agent. Microtubule polymerization inhibitor.
ABT-751 is an orally bioavailable vascular disrupting agaent (VDA) with a broad spectrum of antitumor activity. It binds to the colchicine binding site on beta-tubulin and inhibits polymerization of microtubules.
An inhibitor of microtubule polymerization
| CAS | 141430-65-1 |
|---|---|
| Sinónimos | DTXSID60869913 | N-[2-(4-Hydroxy-phenylamino)-pyridin-3-yl]-4-methoxy-benzenesulfonamide | CCG-264843 | CHEBI:95043 | E-7010 | HMS3672M11 | NCGC00346494-03 | ABT751 | ABT-751 | BDBM50101086 | HMS3654C14 | N-(2-((4-Hydroxyphenyl)amino)-3-pyridinyl)-4-metho |
| Especificações e pureza | ≥98% |
| Condições de armazenamento de armazenamento | Store at 2-8°C |
| Enviado em | Wet ice |
| Product Description | ABT-751 is an orally bioavailable vascular disrupting agaent (VDA) with a broad spectrum of antitumor activity. It binds to the colchicine binding site on beta-tubulin and inhibits polymerization of microtubules. |
| Pubchem Sid | 508810304 |
| Pubchem Sid Url | https://pubchem.ncbi.nlm.nih.gov/substance/508810304 |
| Solubilidade | DMSO ≥73mg/mL Water <1.2mg/mL Ethanol ≥13mg/mL |
| Sensibilidade | Heat Sensitive |
| Número de identificação | MFCD00910291 |
| Número CE | 689-192-0 |
| PubChem CID | 3035714 |
| Fórmula molecular | C18H17N3O4S |